| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |